When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALDR - FDA accepts Alder's application for eptinezumab
Alder BioPharmaceuticals Inc.
The FDA accepts for review Alder BioPharmaceuticals' (NASDAQ:ALDR) marketing application seeking approval for eptinezumab for the prevention of migraine.
More news on: Alder BioPharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,